4 free views remaining today
Dowling-Degos disease
ICD-10 Codes
Related ICD-10:
Description
Dowling-Degos Disease: A Rare Skin Condition
Dowling-Degos disease (DDD) is a rare genetic disorder that affects the skin, characterized by acquired reticular hyperpigmentation in flexural sites [1]. It is an autosomal dominant condition, meaning that a single copy of the mutated gene is enough to cause the disease [8][9].
Key Features:
- Hyperpigmentation: DDD is marked by the appearance of abnormally dark skin coloring (hyperpigmentation) in specific areas of the body, particularly in flexural sites such as the folds of the skin [2][3].
- Reticulate pattern: The hyperpigmentation often takes on a lacy or net-like (reticulate) pattern, which is a distinctive feature of the disease [3][4].
- Adult-onset: DDD typically presents in adult life, with symptoms appearing later in life [2][5].
Causes and Genetics:
Dowling-Degos disease is caused by mutations in specific genes, including keratin 5 and protein O-fucosyltransferase 1 [7]. These genetic mutations lead to the characteristic skin changes associated with the disease.
References:
[1] AS Rice (2023) - Dowling-Degos disease is a rare autosomal dominant disorder characterized by acquired reticular hyperpigmentation in flexural sites. [2] Dowling-Degos disease is a rare genetic disease of the skin that presents in adult life with pigmentation, particularly in the folds of the skin. [3] Aug 1, 2017 - Dowling-Degos disease is a skin condition characterized by a lacy or net-like (reticulate) pattern of abnormally dark skin coloring (hyperpigmentation) [4] P Mohanty (2019) - Dowling-Degos disease is a rare, pigmentary disorder with variable presentations. [5] A rare, genetic, hyperpigmentation of the skin disease characterized by adulthood-onset of reticular, reddish-brown to dark-brown, macular and/or comedone-like ... [6] Dowling-Degos disease (DDD) belongs to the genetically heterogeneous group of reticulate pigment disorders of the skin. [7] Dowling-Degos disease is a rare pigmented skin disorder caused by mutations in keratin 5 and protein O-fucosyltransferase 1. [8] Dowling-Degos disease is an autosomal dominant skin disorder characterised by progressive pigmentation of the skin within body folds. [9] Dowling-Degos disease (DDD) is an autosomal dominant genodermatosis characterized by reticular pigmentation, usually in a flexural distribution.
Additional Characteristics
- Dowling-Degos disease is a rare genetic disorder that affects the skin.
- It is an autosomal dominant condition, meaning that a single copy of the mutated gene is enough to cause the disease.
- DDD is marked by the appearance of abnormally dark skin coloring (hyperpigmentation) in specific areas of the body, particularly in flexural sites such as the folds of the skin.
- The hyperpigmentation often takes on a lacy or net-like (reticulate) pattern, which is a distinctive feature of the disease.
- DDD typically presents in adult life, with symptoms appearing later in life.
- It is caused by mutations in specific genes, including keratin 5 and protein O-fucosyltransferase 1.
Signs and Symptoms
Dowling-Degos Disease Signs and Symptoms
Dowling-Degos disease, a rare genetic skin condition, presents with several distinct signs and symptoms. These include:
- Hyperpigmentation: Abnormally dark skin coloring (hyperpigmentation) in the form of a lacy or net-like (reticulate) pattern [1].
- Reticular hyperpigmentation: A characteristic feature of Dowling-Degos disease, where acquired reticular hyperpigmentation is observed in flexural sites [3].
- Skin lesions: Porcelain-white macules that may persist for several weeks or even years [4].
- Hyperkeratotic papules: Raised, rough patches on the skin [7].
- Hypopigmented macules: Areas of skin with reduced pigmentation [7].
- Comedo-like lesions: Small bumps on the skin that resemble comedones (blackheads) [5][6][7].
- Erythematous papules: Pink or red patches on the skin, which may heal to leave scars [8].
These symptoms are typically observed in flexural areas of the body and can vary in severity from person to person.
Additional Symptoms
- Hypopigmented macules
- Skin lesions
- Erythematous papules
- Hyperkeratotic papules
- Comedo-like lesions
- hyperpigmentation
Diagnostic Tests
Diagnostic Tests for Dowling-Degos Disease
Dowling-Degos disease, a rare genetic skin condition, can be challenging to diagnose. While there is no specific laboratory test that can confirm the diagnosis, several clinical and histological features can aid in its identification.
- Clinical Features: The diagnosis of Dowling-Degos disease is primarily based on clinical features, which include:
- A lacy or net-like (reticulate) pattern of abnormally dark skin coloring [3]
- Reticular, reddish-brown to dark-brown, macular and/or comedone-like lesions [6]
- Skin Biopsy: The diagnosis is confirmed through a skin biopsy, which shows two histological variants:
- A reticulate pattern of pigmentation in the dermis
- A characteristic "lace-like" or "net-like" appearance of the epidermal-dermal junction [2]
Genetic Testing
While genetic testing is not definitive for Dowling-Degos disease, it can be used to identify associated genes. The following genes have been linked to the condition:
- KRT5: A gene that encodes a protein involved in skin cell development and differentiation [1]
- POGLUT1: Another gene that has been associated with Dowling-Degos disease [5]
Diagnostic Tests
Several diagnostic tests can be used to aid in the diagnosis of Dowling-Degos disease, including:
- NGS (Next-Generation Sequencing) screening panel: A comprehensive genetic test that screens for 253 genes, including those associated with skin diseases [9]
- Dowling-Degos disease-specific genetic testing: Tests that specifically target the KRT5, POFUT1, and POGLUT1 genes [9]
It's essential to consult a healthcare professional or a dermatologist for an accurate diagnosis and treatment plan.
References: [1] - Context 1 [2] - Context 2 [3] - Context 3 [5] - Context 5 [6] - Context 6 [9] - Context 9
Additional Diagnostic Tests
- Skin Biopsy
- Clinical Features
- NGS (Next-Generation Sequencing) screening panel
- Dowling-Degos disease-specific genetic testing
Treatment
Dowling-Degos disease (DDD) is a rare skin condition characterized by hyperpigmentation and epidermal cysts. While there are various treatment options available, drug therapy plays a crucial role in managing the symptoms.
Topical Treatments
- Topical steroids may help alleviate itching associated with DDD [3].
- Adapalene gel has been reported to control itch and fade pigmentation in one case study [3].
- Retinoids, such as adapalene and tazarotene, have shown promise due to their anti-inflammatory properties [9]. These medications have been the most successful treatments used for DDD.
Oral Medications
- Sulfone and retinoids are sometimes used in patients with numerous epidermal cysts, although they may not be effective in maintaining remission [8].
Other Therapies
- Laser therapy has been explored as a novel management strategy for DDD. A case study reported successful treatment using intense pulsed light [6].
- Genetic counseling is recommended for affected individuals and their families to discuss the potential inheritance of the condition [7].
It's essential to
Recommended Medications
š Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Dowling-Degos Disease
Dowling-Degos disease (DDD) is a rare genetic skin disorder that presents with pigmentation changes, particularly in the folds of the skin. When diagnosing DDD, it's essential to consider other conditions that may present with similar symptoms. Here are some differential diagnoses for Dowling-Degos disease:
- Galli-Galli disease: A subtype of Dowling-Degos disease characterized by additional pigmentation changes [1].
- Acanthosis nigricans: A skin condition marked by dark, velvety skin patches, particularly in the folds and creases [6][8].
- Naegeli-Franceschetti-Jadassohn syndrome: A rare genetic disorder that affects the skin, hair, and nails, presenting with similar pigmentation changes to DDD [6][8].
- Confluent and reticulated papillomatosis (CRP): A rare skin condition characterized by a reticular pattern of papules and plaques [5][8].
- Reticulate acropigmentation of Kitamura: A rare genetic disorder that affects the skin, presenting with pigmentation changes similar to DDD [7].
Other conditions to consider
In addition to these differential diagnoses, other conditions may also be considered when diagnosing Dowling-Degos disease. These include:
- Familial Dyskeratotic Comedones: A rare genetic disorder that affects the skin, presenting with comedonal lesions and pigmentation changes [3].
- Comedonal Darrier's disease: A rare skin condition characterized by comedonal lesions and pigmentation changes [3].
References
[1] Galli-Galli disease is a subtype of Dowling-Degos disease and is distinguished by the additional finding of ... (Search result 1) [2] Dowling-Degos disease is a rare genetic disease of the skin that presents in adult life with pigmentation, particularly in the folds of the skin. It is also ... (Search result 2) [3] The closest differentials to above described clinical findings include Familial Dyskeratotic Comedones, Comedonal Darrier's disease and acne conglobata. (Search result 3) [4] The diagnosis is very simple when classical features are present, as observed in our cases. We had considered the differential diagnosis of familial ... (Search result 4) [5] A condition called Galli-Galli disease has signs and symptoms similar to those of Dowling-Degos disease. In addition to pigmentation changes ... (Search result 5) [6] Other important diseases in the differential diagnosis include acanthosis nigricans, Naegeli-Franceschetti-Jadassohn syndrome, and confluent and reticulate ... (Search result 6) [7] Diagnosis ; GalliāGalli disease. AD. KRT5 ; Reticulate acropigmentation of Kitamura. AD. ADAM10 ; Haber Syndrome ; Dyschromatosis symmetrica hereditaria ( ... (Search result 7) [8] The differential diagnosis includes acanthosis nigricans, Naegeli-Franceschetti-Jadassohn syndrome, confluent and reticulated papillomatosis ... (Search result 8) [9] Reticulate pigmented anomaly of the flexures, also known as Dowling-Degos disease (DDD) or Dowling-Degos syndrome, is a rare autosomal ... (Search result 9) [10] Dowling-Degos Disease is a rare, pigmentary disorder with variable presentations. The most common among them are hyperpigmented macules and reticulate ... (Search result 10)
Additional Differential Diagnoses
- reticulate acropigmentation of Kitamura
- epidermolysis bullosa simplex with mottled pigmentation
- inflammatory poikiloderma with hair abnormalities and acral keratoses
- Confluent and reticulated papillomatosis (CRP)
- Familial Dyskeratotic Comedones
- disease
- Naegeli-Franceschetti-Jadassohn syndrome
- acanthosis nigricans
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_1282
- owl#annotatedSource
- t336105
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#creation_date
- 2015-01-30T11:04:57Z
- oboInOwl#id
- DOID:0060256
- oboInOwl#created_by
- emitraka
- oboInOwl#hasDbXref
- UMLS_CUI:C3714534
- IAO_0000115
- A pigmentation disease characterized by a reticulate pattern of abnormally dark skin coloring, particularly in the body's folds and creases.
- oboInOwl#hasExactSynonym
- reticular pigment anomaly of flexures
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- relatedICD
- http://example.org/icd10/E88.49
- core#notation
- DOID:0060256
- rdf-schema#label
- Dowling-Degos disease
- rdf-schema#comment
- NT MGI.
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_10123
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.